BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 33660949)

  • 1. Adherence and optimization of angiotensin converting enzyme inhibitor/angiotensin II receptors blockers and beta-blockers in patients hospitalized for acute heart failure.
    Carubelli V; Lombardi C; Specchia C; Peveri G; Oriecuia C; Tomasoni D; Di Pasquale M; Inciardi R; Garrafa E; Metra M
    ESC Heart Fail; 2021 Jun; 8(3):1944-1953. PubMed ID: 33660949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Prescribing Patterns of Renin-Angiotensin System Blockers and Beta-Blockers on Prognosis of Heart Failure.
    Kim HJ; Jo SH; Lee MH; Seo WW; Choi JO; Ryu KH
    Adv Ther; 2020 Sep; 37(9):3839-3849. PubMed ID: 32676928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of Use and Clinical Outcomes with Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Acute Heart Failure and Changes in Kidney Function: An Analysis of the Veterans' Health Administrative Database.
    Mathew RO; Lo KB; Tipparaju P; Phelps E; Sidhu MS; Bangalore S; Herzog C; Vaduganathan M; Tang WHW; Rangaswami J
    Cardiorenal Med; 2021; 11(5-6):226-236. PubMed ID: 34601469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renin-Angiotensin System Inhibition and Lower 30-Day All-Cause Readmission in Medicare Beneficiaries with Heart Failure.
    Sanam K; Bhatia V; Bajaj NS; Gaba S; Morgan CJ; Fonarow GC; Butler J; Deedwania P; Prabhu SD; Wu WC; White M; Love TE; Aronow WS; Fletcher RD; Allman RM; Ahmed A
    Am J Med; 2016 Oct; 129(10):1067-73. PubMed ID: 27262781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initiation, Continuation, or Withdrawal of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Outcomes in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction.
    Gilstrap LG; Fonarow GC; Desai AS; Liang L; Matsouaka R; DeVore AD; Smith EE; Heidenreich P; Hernandez AF; Yancy CW; Bhatt DL
    J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28189999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timing of prescription of angiotensin-converting enzyme inhibitors/angiotensin receptor blockers in patients hospitalized for acute heart failure with reduced/mildly reduced ejection fraction: a retrospective analysis.
    Ishii T; Matsue Y; Matsunaga Y; Iekushi K; Homma Y; Morita Y
    Heart Vessels; 2024 Jan; 39(1):25-34. PubMed ID: 37695543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of combined renin-angiotensin-aldosterone system inhibitor and beta-blocker treatment on outcomes in heart failure with reduced ejection fraction: insights from BIOSTAT-CHF and ASIAN-HF registries.
    Ouwerkerk W; Teng TK; Tromp J; Tay WT; Cleland JG; van Veldhuisen DJ; Dickstein K; Ng LL; Lang CC; Anker SD; Zannad F; Hung CL; Sawhney JPS; Naik A; Shimizu W; Hagiwara N; Wander GS; Anand I; Richards AM; Voors AA; Lam CSP
    Eur J Heart Fail; 2020 Aug; 22(8):1472-1482. PubMed ID: 32583922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discontinuation/Dose Reduction of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers during Acute Decompensated Heart Failure in African-American Patients with Reduced Left-Ventricular Ejection Fraction.
    Kane JA; Kim JK; Haidry SA; Salciccioli L; Lazar J
    Cardiology; 2017; 137(2):121-125. PubMed ID: 28376504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin converting enzyme inhibitors and angiotensin receptor blockers in acute heart failure: invasive hemodynamic parameters and clinical outcomes.
    Lo KB; Toroghi HM; Salacup G; Jiang J; Bhargav R; Quintero E; Balestrini K; Shahzad A; Mathew RO; McCullough PA; Rangaswami J
    Rev Cardiovasc Med; 2021 Mar; 22(1):199-206. PubMed ID: 33792263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Angiotensin Converting Enzyme Inhibitors/Angiotensin Receptors Blockers on Mortality in Acute Heart Failure Patients with Left Ventricular Systolic Dysfunction in the Middle East: Observations from the Gulf Acute Heart Failure Registry (Gulf CARE).
    Al-Zakwani I; Sulaiman K; Al-Lawati JA; Alsheikh-Ali AA; Panduranga P; Al-Habib KF; Al Suwaidi J; Al-Mahmeed W; Al-Faleh H; Elasfar A; Al-Motarreb A; Ridha M; Bulbanat B; Al-Jarallah M; Bazargani N; Asaad N; Amin H
    Curr Vasc Pharmacol; 2018; 16(6):596-602. PubMed ID: 28820057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and Prognostic Impact of Early Treatment with Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers in Patients with Acute Heart Failure.
    Yoshioka K; Matsue Y; Yamaguchi T; Kitai T; Kagiyama N; Okumura T; Kida K; Oishi S; Akiyama E; Suzuki S; Yamamoto M; Kuroda S; Matsumura A; Hirao K
    Am J Cardiovasc Drugs; 2019 Dec; 19(6):597-605. PubMed ID: 31218508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk-treatment mismatch in the pharmacotherapy of heart failure.
    Lee DS; Tu JV; Juurlink DN; Alter DA; Ko DT; Austin PC; Chong A; Stukel TA; Levy D; Laupacis A
    JAMA; 2005 Sep; 294(10):1240-7. PubMed ID: 16160132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discharge use of angiotensin receptor blockers provides comparable effects with angiotensin-converting enzyme inhibitors on outcomes in patients hospitalized for heart failure.
    Tsuchihashi-Makaya M; Furumoto T; Kinugawa S; Hamaguchi S; Goto K; Goto D; Yamada S; Yokoshiki H; Takeshita A; Tsutsui H;
    Hypertens Res; 2010 Mar; 33(3):197-202. PubMed ID: 19960016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discharge treatment with angiotensin-converting enzyme inhibitor/angiotensin receptor blocker after a heart failure hospitalisation is associated with a better prognosis irrespective of left ventricular ejection fraction.
    Vicent L; Cinca J; Vazquez-García R; Gonzalez-Juanatey JR; Rivera M; Segovia J; Pascual-Figal D; Bover R; Worner F; Delgado-Jiménez J; Fernández-Avilés F; Martínez-Sellés M
    Intern Med J; 2019 Dec; 49(12):1505-1513. PubMed ID: 30887642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Outcomes in Heart Failure: A Meta-Analysis.
    Khan MS; Fonarow GC; Ahmed A; Greene SJ; Vaduganathan M; Khan H; Marti C; Gheorghiade M; Butler J
    Circ Heart Fail; 2017 Aug; 10(8):. PubMed ID: 28790052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of angiotensin receptor blocker at discharge in patients with heart failure with reduced ejection fraction: Korean Acute Heart Failure (KorAHF) registry.
    Choi KH; Lee GY; Choi JO; Jeon ES; Lee HY; Cho HJ; Lee SE; Kim MS; Kim JJ; Hwang KK; Chae SC; Baek SH; Kang SM; Choi DJ; Yoo BS; Kim KH; Park HY; Cho MC; Oh BH
    Int J Cardiol; 2018 Apr; 257():168-176. PubMed ID: 29506690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study.
    Teng TK; Tromp J; Tay WT; Anand I; Ouwerkerk W; Chopra V; Wander GS; Yap JJ; MacDonald MR; Xu CF; Chia YM; Shimizu W; ; Richards AM; Voors A; Lam CS
    Lancet Glob Health; 2018 Sep; 6(9):e1008-e1018. PubMed ID: 30103979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conventional heart failure therapy in cardiac ATTR amyloidosis.
    Ioannou A; Massa P; Patel RK; Razvi Y; Porcari A; Rauf MU; Jiang A; Cabras G; Filisetti S; Bolhuis RE; Bandera F; Venneri L; Martinez-Naharro A; Law S; Kotecha T; Virsinskaite R; Knight DS; Emdin M; Petrie A; Lachmann H; Wechelakar A; Petrie M; Hughes A; Freemantle N; Hawkins PN; Whelan C; McMurray JJV; Gillmore JD; Fontana M
    Eur Heart J; 2023 Aug; 44(31):2893-2907. PubMed ID: 37216684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heart failure oral therapies at discharge are associated with better outcome in acute heart failure: a propensity-score matched study.
    Gayat E; Arrigo M; Littnerova S; Sato N; Parenica J; Ishihara S; Spinar J; Müller C; Harjola VP; Lassus J; Miró Ò; Maggioni AP; AlHabib KF; Choi DJ; Park JJ; Zhang Y; Zhang J; Januzzi JL; Kajimoto K; Cohen-Solal A; Mebazaa A;
    Eur J Heart Fail; 2018 Feb; 20(2):345-354. PubMed ID: 28849606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescription in patients with chronic heart failure and multimorbidity attended in primary care.
    Frigola-Capell E; Verdú-Rotellar JM; Comin-Colet J; Davins-Miralles J; Hermosilla E; Wensing M; Suñol R
    Qual Prim Care; 2013; 21(4):211-9. PubMed ID: 24041138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.